Linzesshcp - linzesshcp.com : IBS-C and CIC Treatments

2.17 Rating by ClearWebStats

linzesshcp.com is 1 decade 1 year 8 months old. This website has a #6,171,142 rank in global traffic. It has a .com as an domain extension. This website has a Google PageRank of 3 out of 10. This domain is estimated value of $ 8.95 and has a daily earning of $ 0.15. While no active threats were reported recently by users, linzesshcp.com is SAFE to browse.

Updated 9 years 5 months ago

Get Custom Widget

Traffic Report of Linzesshcp

Daily Unique Visitors:	78
Daily Pageviews:	156

Estimated Valuation

Income Per Day:	$ 0.15
Estimated Worth:	$ 8.95

Search Engine Indexes

Google Indexed Pages:	Not Applicable
Yahoo Indexed Pages:	Not Applicable
Bing Indexed Pages:	Not Applicable

Search Engine Backlinks

Google Backlinks:	Not Applicable
Bing Backlinks:	Not Applicable
Alexa BackLinks:	1

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	Not Applicable
WOT Trustworthiness:	Excellent
WOT Privacy:	Excellent
WOT Child Safety:	Excellent

Website Ranks & Scores

Google Pagerank:
Alexa Rank:	6,171,142
Domain Authority:	Not Applicable

Google Pagerank

PR 3 out of 10

PageSpeed Score

Siteadvisor Rating

Not Applicable

Where is linzesshcp.com server located?

Hosted IP Address:

208.97.227.173

View other site hosted with linzesshcp.com

Hosted Country:

Location Latitude:

40.1215

Location Longitude:

-75.3399

Social Engagement

Facebook Shares:	4
Facebook Likes:	Not Applicable
Facebook Comments:	Not Applicable
Twitter Count (Tweets):	Not Applicable
Linkedin Shares:	Not Applicable
Delicious Shares:	Not Applicable

Page Resources Breakdown

Homepage Links Analysis

View linzesshcp.com homepage link analysis

Page Title of Linzesshcp

IBS-C and CIC Treatments — LINZESS (linaclotide)

Meta Description of Linzesshcp

Find information for healthcare professionals on LINZESS (linaclotide), a prescription medication that treats irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) symptoms. INDICATIONS AND USAGE. LINZESS (linaclotide) is indicated in adults for the treatment of both irritable bowel syndrome with constipation (IBSC) and chronic idiopathic constipation (CIC). IMPORTANT SAFETY INFORMATION WARNING: PEDIATRIC RISK. LINZESS is contraindicated in pediatric patients up to 6 years of age. Use should be avoided in pediatric patients 6 through 17 years of age. In nonclinical studies, administration of a single, clinically relevant adult oral dose of linaclotide caused deaths in young juvenile mice. Contraindications. LINZESS is contraindicated in pediatric patients up to 6 years of age. LINZESS is contraindicated in patients with known or suspected mechanical gastrointestinal obstruction. Warnings and Precautions. Pediatric Risk. LINZESS is contraindicated in pediatric patients up to 6 years of age. In nonclinical studies, deaths occurred within 24 hours in young juvenile mice (1 to 3 week-old mice; approximately equivalent to human pediatric patients less than 2 years of age) following administration of one or two daily oral doses of linaclotide. Use of LINZESS should be avoided in pediatric patients 6 through 17 years of age. Linaclotide did not cause deaths in older juvenile mice (approximately equivalent to humans age 12 to 17 years). Although there were no deaths in older juvenile mice, given the deaths in young juvenile mice and the lack of clinical safety and efficacy data in pediatric patients, use of LINZESS should be avoided in pediatric patients 6 through 17 years of age. Diarrhea. Diarrhea was the most common adverse reaction of LINZESS-treated patients in the pooled IBS-C and CIC double-blind placebo-controlled trials. Severe diarrhea was reported in 2% of LINZESS-treated patients. The incidence of diarrhea was similar in the IBS-C and CIC populations. Patients should be instructed to stop LINZESS if severe diarrhea occurs and to contact their healthcare provider, who should consider dose suspension. Adverse Reactions. In IBS-C clinical trials, the most common adverse reactions in LINZESS-treated patients (incidence ≥2% and greater than placebo) were diarrhea (20% vs 3% placebo), abdominal pain (7% vs 5%), flatulence (4% vs 2%), headache (4% vs 3%), viral gastroenteritis (3% vs 1%) and abdominal distension (2% vs 1%). In CIC clinical trials, the most common adverse reactions in LINZESS-treated patients (incidence ≥2% and greater than placebo) were diarrhea (16% vs 5% placebo), abdominal pain (7% vs 6%), flatulence (6% vs 5%), upper respiratory tract infection (5% vs 4%), sinusitis (3% vs 2%) and abdominal distension (3% vs 2%).

Meta Tags of Linzesshcp

linzess, linaclotide, ibs c treatment, ibs c medication, chronic constipation treatment

Website Inpage Analysis

H1 Headings:	Not Applicable	H2 Headings:	Not Applicable
H3 Headings:	Not Applicable	H4 Headings:	Not Applicable
H5 Headings:	Not Applicable	H6 Headings:	Not Applicable
Total IFRAMEs:	Not Applicable	Total Images:	29
Google Adsense:	Not Applicable	Google Analytics:	Not Applicable

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Cache-Control: no-cache
Pragma: no-cache
Content-Type: text/html; charset=utf-8
Content-Encoding: gzip
Expires: -1
Vary: Accept-Encoding
Server: Microsoft-IIS/7.5
X-Powered-By: ASP.NET
X-AspNet-Version: 2.0.50727
Date: Tue, 18 Nov 2014 07:48:08 GMT
Content-Length: 10224

Domain Information for linzesshcp.com

Domain Registrar:	NETWORK SOLUTIONS, LLC.
Registration Date:	2012-08-28 1 decade 1 year 8 months ago
Last Modified:	2013-06-26 1 decade 10 months 2 weeks ago
Expiration Date:	2018-08-28 5 years 8 months 2 weeks ago

Domain Nameserver Information

Host	IP Address	Country
ns1.frx.com	69.27.233.247	United States
ns2.frx.com	63.76.230.145	United States
ns3.frx.com	65.69.34.3	United States
ns4.frx.com	69.45.100.149	United States

DNS Record Analysis

Host	Type	TTL	Extra
linzesshcp.com	A	21597	IP:208.97.227.173
linzesshcp.com	NS	21599	Target:ns4.frx.com
linzesshcp.com	NS	21599	Target:ns1.frx.com
linzesshcp.com	NS	21599	Target:ns3.frx.com
linzesshcp.com	NS	21599	Target:ns2.frx.com
linzesshcp.com	SOA	899	MNAME:ns1.frx.com RNAME:hostmaster.frx.com Serial:15 Refresh:1800 Retry:300 Expire:2592000

Similarly Ranked Websites to Linzesshcp

Error 406 - Not Acceptable

- cardcybermuseum.com

6,171,160

$ 8.95

Seven Haunted Seas — New Video Games

- sevenhauntedseas.com

New Video Games

6,171,165

$ 8.95

Groovy Cats N Dogs | Pet Blog

- groovycatsndogs.com

Pet Blog

6,171,187

$ 8.95

Reifen Haub :: Winterreifen Sommerreifen Autoreifen Frankfurt Reifenhandel

- reifen-haub.de

Reifen Frankfurt Ihr servicestarker Reifenhändler Reifen Haub in Frankfurt für Autoreifen Sommerreifen Winterreifen Reifenservice Flottenmanagement in Frankfurt Autoreifen

6,171,195

$ 8.95

Fatima and Marian Apparitions

- fatimarevelation.com

One of the most shocking 21st century reports on the real agenda of the Illuminati.

6,171,203

$ 8.95

Web stats for Linzesshcp - linzesshcp.com

Traffic Report of Linzesshcp

Estimated Valuation

Search Engine Indexes

Search Engine Backlinks

Safety Information

Website Ranks & Scores

PageSpeed Score

Siteadvisor Rating

Where is linzesshcp.com server located?

Social Engagement

Page Resources Breakdown

Homepage Links Analysis

Website Inpage Analysis

HTTP Header Analysis

Domain Information for linzesshcp.com

Domain Nameserver Information

DNS Record Analysis

Similarly Ranked Websites to Linzesshcp

Error 406 - Not Acceptable

Seven Haunted Seas — New Video Games

Groovy Cats N Dogs | Pet Blog

Reifen Haub :: Winterreifen Sommerreifen Autoreifen Frankfurt Reifenhandel

Fatima and Marian Apparitions